Security Snapshot

MEDIFAST INC - Common Stock, $0.001 par value (MED) Institutional Ownership

CUSIP: 58470H101

13F Institutional Holders and Ownership History from Q1 2014 to Q3 2026

13F reference period

Q3 2026

Institutions Reporting

38

Shares (Excl. Options)

4.02MFull value: 4,022,296 · shares · 30 Sep 2026

Price

$11.52

The headline uses the Q3 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended.

Save this security page for your next review

Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0%
Share change
+111,980
Value change
+$1,445,713
Number of holders
38
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
11,136,521
SEC-reported price per share
$11.52
Insider filing price
$11.52
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source

Key facts

  • MED - MEDIFAST INC - Common Stock, $0.001 par value is tracked under CUSIP 58470H101.
  • 38 institutions reported positions in Q3 2026.
  • 6 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 110 to 38 between Q2 2026 and Q3 2026.
  • SEC-reported value moved from
    $87.66MFull value: $87,656,991 · USD · 30 Jun 2026
    to
    $46.34MFull value: $46,337,734 · USD · 30 Sep 2026
    .

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 38 institutions filings for Q3 2026.

Open SEC evidence

Security key

58470H101

13F reference period

Q3 2026

13F holders

38

13D/G owners

6

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
6
Security
MED
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Steamboat Capital Partners, LLC 7.1% +18% $7,622,281 +$1,283,113 790,693 +20% Steamboat Capital Partners, LLC 20 Aug 2026
RENAISSANCE TECHNOLOGIES LLC 7% -14% $8,139,429 -$1,212,093 773,710 -13% Renaissance Technologies LLC 02 Jan 2026
SUSQUEHANNA SECURITIES, LLC 5.3% +390% $6,271,446 +$4,680,724 587,214 +294% Susquehanna Portfolio Strategies, LLC 30 Jun 2026
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 3.6% -36% $4,239,917 +$4,239,917 396,996 CHARLES SCHWAB INVESTMENT MANAGEMENT INC 30 Jun 2026
BlackRock, Inc. 2.9% $3,473,756 327,404 BlackRock, Inc. 30 Jun 2026
Citadel Securities GP LLC 2.6% -56% $3,094,541 -$4,551,378 289,751 -60% Kenneth Griffin 30 Jun 2026
As of 30 Sep 2026, 38 institutional investors reported holding
4.02MFull value: 4,022,296 · shares · 30 Sep 2026
shares of MEDIFAST INC - Common Stock, $0.001 par value (MED). This represents 36% of the company’s total
11.14MFull value: 11,136,521 · shares · Stored outstanding share count
outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
36%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
RENAISSANCE TECHNOLOGIES LLC 7.7% 858,513 +10% 0.01% $9,890,070
VANGUARD CAPITAL MANAGEMENT LLC 4% 446,614 0% 0% $5,144,993
AMERICAN CENTURY COMPANIES INC 3.9% 439,221 +38% 0% $5,059,826
DIMENSIONAL FUND ADVISORS LP 3.4% 373,439 +2.8% 0% $4,302,066
MARSHALL WACE, LLP 3.2% 352,704 +46% 0% $4,063,150
MORGAN STANLEY 2.2% 244,294 -16% 0% $2,814,274
Peapod Lane Capital LLC 1.9% 207,502 -6.8% 1.8% $2,390,423
COMMONS CAPITAL, LLC 1.7% 184,432 +23% 1.4% $2,124,657
Quinn Opportunity Partners LLC 1.1% 127,112 0% 0.08% $1,464,330
BNP PARIBAS FINANCIAL MARKETS 1.1% 124,997 0% $1,439,965
GEODE CAPITAL MANAGEMENT, LLC 1.1% 117,440 -3% 0% $1,353,732
RBF Capital, LLC 0.75% 83,244 -24% 0.04% $958,971
FEDERATED HERMES, INC. 0.74% 82,786 +19% 0% $953,695
Virtus Family Office LLC 0.71% 79,060 0% 0.7% $910,771
Empowered Funds, LLC 0.59% 66,054 -0.08% 0% $760,942
VANGUARD FIDUCIARY TRUST CO 0.57% 63,337 0% 0% $729,642
STATE STREET CORP 0.49% 54,855 +4.8% 0% $631,930
Quantinno Capital Management LP 0.46% 51,588 -38% 0% $594,294
MAI Capital Management 0.19% 21,016 0% $242,104
LITTLEJOHN FINANCIAL SERVICES, INC. 0.18% 19,834 +43% 0.17% $228,488
AXQ CAPITAL, LP 0.12% 13,125 0.02% $151,200
Arax Advisory Partners 0.04% 4,080 -45% 0% $47,002
Vanguard Global Advisers, LLC 0.04% 3,922 0% 0% $45,181
GAMMA Investing LLC 0.01% 900 -14% 0% $10,368
GROUP ONE TRADING LLC 0.01% 700 0% $8,064

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
51
Headline period
Q3 2026
Rows shown
1-25 of 51
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q3 4,022,296 $46,337,734 +$1,445,713 $11.52 38
2026 Q2 8,260,710 $87,656,991 -$3,919,385 $10.61 110
2026 Q1 8,602,504 $87,639,892 +$5,082,323 $10.19 112
2025 Q4 8,054,031 $86,511,314 -$13,371,466 $10.68 108
2025 Q3 9,231,593 $126,175,997 +$8,181,617 $13.67 121
2025 Q2 8,622,468 $121,151,406 +$5,639,293 $14.05 119
2025 Q1 8,243,161 $111,111,582 -$12,305,056 $13.48 122
2024 Q4 8,923,034 $157,184,942 -$4,774,951 $17.62 129
2024 Q3 9,163,523 $175,430,199 -$26,787,069 $19.14 139
2024 Q2 10,429,064 $227,557,862 -$54,011,494 $21.82 157
2024 Q1 11,481,133 $439,976,756 +$30,953,025 $38.32 184
2023 Q4 10,327,821 $694,235,115 +$41,374,328 $67.22 216
2023 Q3 9,665,221 $724,203,937 -$8,659,421 $74.85 222
2023 Q2 9,669,541 $891,905,428 -$61,913,795 $92.16 234
2023 Q1 10,234,973 $1,061,341,644 +$86,814,952 $103.67 261
2022 Q4 9,414,287 $1,086,305,314 -$11,929,284 $115.35 273
2022 Q3 9,527,598 $1,033,430,006 -$59,199,848 $108.36 246
2022 Q2 9,687,197 $1,748,984,608 -$24,539,021 $180.51 271
2022 Q1 9,926,997 $1,697,651,687 +$16,771,177 $170.78 279
2021 Q4 9,781,823 $2,049,223,135 -$47,927,471 $209.43 293
2021 Q3 9,994,460 $1,926,341,111 -$26,844,446 $192.64 289
2021 Q2 9,961,273 $2,819,353,209 +$76,744,435 $282.98 294
2021 Q1 9,730,211 $2,062,202,677 -$49,579,570 $211.82 270
2020 Q4 9,997,947 $1,963,691,126 -$25,626,899 $196.34 255
2020 Q3 10,066,415 $1,655,403,260 -$331,394,781 $164.45 237
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .